药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Sulfacytine
Fimasartan
The risk or severity of hypotension, hyperkalemia, and reduced intravascular volume can be increased when Canagliflozin is combined with Fimasartan.
Sulfacytine
Azilsartan medoxomil
The risk or severity of hypotension, hyperkalemia, and reduced intravascular volume can be increased when Canagliflozin is combined with Azilsartan medoxomil.
Sulfacytine
Saralasin
The risk or severity of hypotension, hyperkalemia, and reduced intravascular volume can be increased when Canagliflozin is combined with Saralasin.
Sulfacytine
Tasosartan
The risk or severity of hypotension, hyperkalemia, and reduced intravascular volume can be increased when Canagliflozin is combined with Tasosartan.
Sulfacytine
Saprisartan
The risk or severity of hypotension, hyperkalemia, and reduced intravascular volume can be increased when Canagliflozin is combined with Saprisartan.
Sulfacytine
Forasartan
The risk or severity of hypotension, hyperkalemia, and reduced intravascular volume can be increased when Canagliflozin is combined with Forasartan.
Sulfacytine
Naloxegol
The serum concentration of Naloxegol can be increased when it is combined with Canagliflozin.
Sulfacytine
Ledipasvir
The serum concentration of Ledipasvir can be increased when it is combined with Canagliflozin.
Sulfacytine
Edoxaban
The serum concentration of Edoxaban can be increased when it is combined with Canagliflozin.
Sulfacytine
Afatinib
The serum concentration of Afatinib can be increased when it is combined with Canagliflozin.
Practolol
Somapacitan
The serum concentration of the active metabolites of Fluticasone furoate can be decreased when Fluticasone furoate is used in combination with Somapacitan.
Practolol
Satralizumab
The serum concentration of Fluticasone furoate can be decreased when it is combined with Satralizumab.
Practolol
Abametapir
The serum concentration of Fluticasone furoate can be increased when it is combined with Abametapir.
Practolol
Inebilizumab
The risk or severity of infection can be increased when Fluticasone furoate is combined with Inebilizumab.
Practolol
Tucatinib
The metabolism of Tucatinib can be decreased when combined with Fluticasone furoate.
Practolol
Ozanimod
The metabolism of Ozanimod can be decreased when combined with Fluticasone furoate.
Practolol
Mebutizide
The risk or severity of electrolyte imbalance can be increased when Fluticasone furoate is combined with Mebutizide.
Practolol
Cyclopenthiazide
The risk or severity of electrolyte imbalance can be increased when Fluticasone furoate is combined with Cyclopenthiazide.
Practolol
Magnesium
The serum concentration of Magnesium can be decreased when it is combined with Fluticasone furoate.
Practolol
Fosphenytoin
The serum concentration of Fosphenytoin can be decreased when it is combined with Fluticasone furoate.